Login
$ABEO
$2.62 +$0.02 (0.77%) After hours

$ABEO SEC Filings

Filed On Filing
16 Nov 2026 SCHEDULE 13G
16 Nov 2026 Form 4: Charles Faith L., Director

Bought 15,000 shares ($34.3K)

13 Nov 2026 SCHEDULE 13G/A
12 Nov 2026 SCHEDULE 13G/A
09 Nov 2026 10-Q
09 Nov 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

– Q3 net ZEVASKYN revenue of $13.5 million, up 18% sequentially over Q2 –

09 Nov 2026 8-K: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +2 more

This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of November 6, 2026, by and among Abeona Therapeutics Inc., a Delaware corporation (the “Company”), and each of the entities listed on Exhibit A attached to this Agreement...

23 Oct 2026 SCHEDULE 13D
29 Sep 2026 Form 4: Seshadri Vishwas, Director

Sold 19,608 shares ($101K)

29 Sep 2026 Form 4: Vazzano Joseph Walter, Chief Financial Officer

Sold 9,191 shares ($47.4K)

29 Sep 2026 Form 4: O'Malley Brendan M., SVP, Chief Legal Officer

Sold 6,727 shares ($34.7K)

29 Sep 2026 Form 4: Vasanthavada Madhav, Chief Commercial Officer

Sold 4,902 shares ($25.3K)

29 Sep 2026 144
29 Sep 2026 144
29 Sep 2026 144
29 Sep 2026 144
15 Sep 2026 8-K: Regulation FD Disclosure

Abeona Therapeutics Inc. is furnishing in this Current Report on Form 8-K an updated investor presentation (the “Investor Presentation”) that it expects to use, either in whole or in part, on September 15, 2026 at the H.C. Wainwright 28t...

01 Sep 2026 Form 4: Alvino Mark, Director

Sold 15,000 shares ($88K)

01 Sep 2026 144
14 Aug 2026 SCHEDULE 13G/A

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support